v3.25.3
Condensed Consolidated Statements of Changes in Equity (Unaudited) - USD ($)
$ in Millions
Total
Common stock
Treasury stock
Additional paid-in capital
Retained earnings
Accumulated other comprehensive income (loss) – net
Equity attributable to noncontrolling interests
Equity, beginning balance (in shares) at Dec. 31, 2023   455,000,000          
Equity, beginning balance at Dec. 31, 2023 $ 7,145 $ 5 $ 0 $ 6,493 $ 1,326 $ (691) $ 12
Treasury stock, beginning balance (in shares) at Dec. 31, 2023     0        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of shares under equity awards, net of shares withheld for taxes and other (in shares)   2,000,000          
Issuance of shares under equity awards, net of shares withheld for taxes and other (59)   $ (25) (34)      
Net income attributable to GE HealthCare 1,272       1,272    
Dividends declared (41)       (41)    
Other comprehensive income (loss) attributable to GE HealthCare (80)         (80)  
Changes in equity attributable to noncontrolling interests 6           6
Share-based compensation 92     92      
Equity, ending balance (in shares) at Sep. 30, 2024   457,000,000          
Equity, ending balance at Sep. 30, 2024 8,335 $ 5 $ (25) 6,551 2,558 (771) 18
Treasury stock, ending balance (in shares) at Sep. 30, 2024     0        
Equity, beginning balance (in shares) at Jun. 30, 2024   457,000,000          
Equity, beginning balance at Jun. 30, 2024 7,817 $ 5 $ 0 6,540 2,101 (845) 16
Treasury stock, beginning balance (in shares) at Jun. 30, 2024     0        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of shares under equity awards, net of shares withheld for taxes and other (35)   $ (25) (10)      
Net income attributable to GE HealthCare 470       470    
Dividends declared (14)       (14)    
Other comprehensive income (loss) attributable to GE HealthCare 74         74  
Changes in equity attributable to noncontrolling interests 2           2
Share-based compensation 21     21      
Equity, ending balance (in shares) at Sep. 30, 2024   457,000,000          
Equity, ending balance at Sep. 30, 2024 $ 8,335 $ 5 $ (25) 6,551 2,558 (771) 18
Treasury stock, ending balance (in shares) at Sep. 30, 2024     0        
Equity, beginning balance (in shares) at Dec. 31, 2024 457,246,971 457,000,000          
Equity, beginning balance at Dec. 31, 2024 $ 8,464 $ 5 $ (25) 6,583 3,262 (1,379) 18
Treasury stock, beginning balance (in shares) at Dec. 31, 2024 291,053   0        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of shares under equity awards, net of shares withheld for taxes and other (in shares)   1,000,000          
Issuance of shares under equity awards, net of shares withheld for taxes and other $ (16)     (16)      
Repurchase of common stock (in shares) 2,800,000   3,000,000        
Repurchase of common stock $ (200)   $ (200)        
Net income attributable to GE HealthCare 1,495       1,495    
Dividends declared (48)       (48)    
Other comprehensive income (loss) attributable to GE HealthCare 223         223  
Changes in equity attributable to noncontrolling interests 4           4
Share-based compensation $ 93     93      
Equity, ending balance (in shares) at Sep. 30, 2025 458,619,612 459,000,000          
Equity, ending balance at Sep. 30, 2025 $ 10,016 $ 5 $ (225) 6,661 4,709 (1,156) 23
Treasury stock, ending balance (in shares) at Sep. 30, 2025 3,107,626   3,000,000        
Equity, beginning balance (in shares) at Jun. 30, 2025   458,000,000          
Equity, beginning balance at Jun. 30, 2025 $ 9,733 $ 5 $ (125) 6,628 4,295 (1,090) 21
Treasury stock, beginning balance (in shares) at Jun. 30, 2025     2,000,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of shares under equity awards, net of shares withheld for taxes and other $ (4)     (4)      
Repurchase of common stock (in shares) 1,400,000   1,000,000        
Repurchase of common stock $ (100)   $ (100)        
Net income attributable to GE HealthCare 446       446    
Dividends declared (32)       (32)    
Other comprehensive income (loss) attributable to GE HealthCare (66)         (66)  
Changes in equity attributable to noncontrolling interests 2           2
Share-based compensation $ 37     37      
Equity, ending balance (in shares) at Sep. 30, 2025 458,619,612 459,000,000          
Equity, ending balance at Sep. 30, 2025 $ 10,016 $ 5 $ (225) $ 6,661 $ 4,709 $ (1,156) $ 23
Treasury stock, ending balance (in shares) at Sep. 30, 2025 3,107,626   3,000,000